Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

NCT07285460

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • The Luskin Orthopaedic Institute for Children- Site Number : 8400013 Los Angeles, California, United States
  • The Center for Inherited Blood Disorders- Site Number : 8400009 Orange, California, United States
  • Cure 4 The Kids Foundation- Site Number : 8400001 Las Vegas, Nevada, United States
  • Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400008 Hackensack, New Jersey, United States
View all 30 locations
View Trial Details
Recruiting

Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT06544785

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • H. General Univ. de Alicante Alicante, Spain
  • H. Clínic de Barcelona Barcelona, Spain
  • H. Vall d' Hebron Barcelona, Spain
  • Hospital del Mar Barcelona, Spain
View all 19 locations
View Trial Details
Recruiting

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

NCT04068597

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +27 more
Locations
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Community Health Network Indianapolis, Indiana, United States
  • The Center for Cancer and Blood Disorders (CCBD) Bethesda, Maryland, United States
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
View all 39 locations
View Trial Details
Recruiting

Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.

NCT06071624

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +11 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida 33136 Miami, Florida, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Albert Einstein Health Network The Bronx, New York, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

NCT05664737

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Local Institution - 0008 Halifax, Nova Scotia, Canada
  • Sun Yat-sen Memorial Hospital, Sun Yat-Sen University Guangzhou, GD, China
  • Nanfang Hospital of Southern Medical University Guangzhou, GD, China
  • The First People's Hospital of Foshan Foshan, Guangdong, China
View all 36 locations
View Trial Details

Related conditions